# FDA drug recall: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per B

> recall · VERIFIED · 2026-06-12

Firm: Boehringer Ingelheim Pharmaceuticals, Inc. · Class II · CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

- Company: Boehringer Ingelheim Pharmaceuticals, Inc.
- Sector: therapeutics
- Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.